Coya Therapeutics Files 8-K
Ticker: COYA · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1835022
| Field | Detail |
|---|---|
| Company | Coya Therapeutics, Inc. (COYA) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Coya Therapeutics filed an 8-K, but the details are scarce.
AI Summary
Coya Therapeutics, Inc. filed an 8-K on July 29, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or other named entities beyond the company itself.
Why It Matters
This 8-K filing indicates that Coya Therapeutics, Inc. has reported an event requiring immediate disclosure to the SEC, though the specifics are not detailed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and lacks specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Registrant
- July 29, 2025 (date) — Date of earliest event reported
FAQ
What specific event triggered this 8-K filing for Coya Therapeutics, Inc.?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' that triggered the report.
When was this 8-K filing submitted to the SEC?
The filing was submitted on July 29, 2025.
What is Coya Therapeutics, Inc.'s principal executive office address?
The principal executive offices are located at 5850 San Felipe St., Suite 500, Houston, Texas 77057.
What is Coya Therapeutics, Inc.'s telephone number?
The registrant's telephone number, including area code, is 800 587-8170.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Coya Therapeutics, Inc. (COYA).